17 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
to be immaterial, could materially and adversely affect our business, financial condition, results of operations and prospects, and reputation … , unexpected characteristics, or other SAEs occur, our clinical trials could be suspended or terminated, and our business and reputation could suffer
ARS
5s0jmkviso7ttr8i
28 Apr 23
Annual report to shareholders
12:00am
DEF 14A
l10q8ht6ulxi7l9sfo7k
11 Aug 22
Definitive proxy
4:04pm
10-K
a94yrb8pvmlautfnzj
21 Mar 22
Annual report
4:19pm
8-K
EX-10.1
d3r6r618843h47a
19 Jan 22
Entry into a Material Definitive Agreement
4:19pm
424B4
svgh5nwg
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
f2l7w35f nuu
19 Jul 21
IPO registration (amended)
6:09am
S-1
4ly2qk4 ang2p9f
1 Jul 21
IPO registration
4:05pm
S-1
EX-10.26
p2pdnzjsb0gedl0fe4cq
1 Jul 21
IPO registration
4:05pm
DRS/A
nq9lxa
11 Jun 21
Draft registration statement (amended)
12:00am
DRS
EX-10.23
m6gsn 6nfna6sq
7 May 21
Draft registration statement
12:00am
DRS
fmy k0k6gap
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next